Data protection Impressum

Personalized Medicine

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs healthy controls. The blue-to-white color scale indicates more pronounced tau loads, with pink-white areas representing those with the highest accumulation.

HUG and UNIGE unveil the next frontier in Alzheimer’s diagnosis

15 August 2023

The canton of Bern, with its continual focus on advancing medicine through research, technology, and collaboration, stands as destination rich in opportunities for companies aiming to grow and innovate in the fields of medicine and life sciences.

Bern’s thriving ecosystem for life sciences innovation

9 August 2023

This discovery provides insight into the complex ecosystem of the tumor microenvironment and offers a new perspective on the treatment of cancer, particularly in the field of oncology.

UNIGE researchers lead breakthrough in understanding tumor growth

8 August 2023

Since its Observer Country status since December 2015, Switzerland has participated in over 20 multinational clinical trials and infrastructure projects under the ECRIN banner, including platform trials on COVID-19.

European clinical research infrastructure bolstered as Switzerland becomes ECRIN member

5 July 2023

Innovative Western Switzeland start-ups take center stage in global awards

20 June 2023

Axe Santé, the canton of Valais’ center for sustainable health technologies

19 June 2023

Revolutionary mRNA vaccine against melanoma to be tested in Geneva

13 June 2023

Revolutionary breakthrough in prostate cancer treatment at the University of Bern

12 June 2023

Brain Computer Interface restores mobility to a paraplegic

24 May 2023

Alcon inaugurates its global headquarters in Geneva

15 May 2023

1 … 6 7 8 9 10 11 12 13 14 … 17